Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
- Status
- RECRUITING
- Phase
- PHASE2
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Retifanlimab and Ruxolitinib In Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB123667 in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Status
- RECRUITING
- Phase
- PHASE3
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Status
- RECRUITING
- Phase
- PHASE2
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Status
- RECRUITING
- Phase
- PHASE2
Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease
- Status
- RECRUITING
- Phase
- PHASE2
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Status
- RECRUITING
- Phase
- PHASE1
Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1